A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function
- PMID: 8798776
- DOI: 10.1074/jbc.271.40.24962
A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function
Abstract
Protein kinase C (PKC) isozymes translocate to unique subcellular sites following activation. We previously suggested that translocation of activated isozymes is required for their function and that in addition to binding to lipids, translocation involves binding of the activated isozymes to specific anchoring proteins (receptors for activated protein kinase C. Using cultured cardiomyocytes we identified inhibitors, the V1 fragment of epsilonPKC (epsilonV1), and an 8-amino acid peptide derived from it that selectively inhibited the translocation of epsilonPKC. Inhibition of epsilonPKC translocation but not inhibition of delta or betaPKC translocation specifically blocked phorbol ester- or norepinephrine-mediated regulation of contraction. These isozyme-selective translocation inhibitors provide novel tools to determine the function of individual PKC isozymes in intact cells.
Similar articles
-
Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells.J Biol Chem. 1997 Jan 17;272(3):1417-20. doi: 10.1074/jbc.272.3.1417. J Biol Chem. 1997. PMID: 8999804
-
Isozyme-specific inhibitors of protein kinase C translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret.J Physiol. 1999 Jun 15;517 ( Pt 3)(Pt 3):709-20. doi: 10.1111/j.1469-7793.1999.0709s.x. J Physiol. 1999. PMID: 10358112 Free PMC article.
-
Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels.Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2658-64. doi: 10.1152/ajpheart.2000.279.6.H2658. Am J Physiol Heart Circ Physiol. 2000. PMID: 11087218
-
Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation.Pharmacol Res. 1999 Apr;39(4):253-9. doi: 10.1006/phrs.1998.0418. Pharmacol Res. 1999. PMID: 10208754 Review.
-
Localization, anchoring, and functions of protein kinase C isozymes in the heart.J Mol Cell Cardiol. 2001 Jul;33(7):1301-7. doi: 10.1006/jmcc.2001.1400. J Mol Cell Cardiol. 2001. PMID: 11437536 Review.
Cited by
-
An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein Interactions.Int J Mol Sci. 2023 Dec 15;24(24):17504. doi: 10.3390/ijms242417504. Int J Mol Sci. 2023. PMID: 38139336 Free PMC article. Review.
-
Epsilon protein kinase C lengthens the quiescent period between spontaneous contractions in rat ventricular cardiac myocytes and trabecula.Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370(4):251-61. doi: 10.1007/s00210-004-0979-5. Epub 2004 Sep 25. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15452687
-
alphaKAP is an anchoring protein for a novel CaM kinase II isoform in skeletal muscle.EMBO J. 1998 Oct 1;17(19):5598-605. doi: 10.1093/emboj/17.19.5598. EMBO J. 1998. PMID: 9755160 Free PMC article.
-
Regulation of sodium channel activity by phosphorylation.Semin Cell Dev Biol. 2011 Apr;22(2):160-5. doi: 10.1016/j.semcdb.2010.10.002. Epub 2010 Oct 13. Semin Cell Dev Biol. 2011. PMID: 20950703 Free PMC article. Review.
-
Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.PLoS One. 2012;7(4):e35630. doi: 10.1371/journal.pone.0035630. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536418 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
